8i Acquisition 2 extends due diligence for EUDA Health combination to June 15, 2022

EUDA Health Holdings Ltd

Parties amended the Share Purchase Agreement on May 30, 2022.
Due diligence review period extended from May 31, 2022 to June 15, 2022.
Amendment involves LAX, EUDA Health, Watermark Developments, and representative Kwong Yeow Liew.
Business combination to be effected through purchase of all EUDA Health shares by LAX.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.